EXPERT OPIN DRUG SAF 润色咨询

Expert Opinion On Drug Safety

出版年份:2002 年文章数:1611 投稿命中率: 开通期刊会员,数据随心看

出版周期:Bimonthly 自引率:2.9% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

投稿信息

投稿信息
审稿费用
暂无数据
版面费用
暂无数据
中国人发表比例
2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%)
自引率
2.9 %
年文章数
1611
期刊官网
点击查看 (点击次数:5432)
点击查看 (点击次数:1833次)
作者需知
暂无数据
偏重的研究方向
暂无数据
期刊简介
稿件收录要求
Published by Informa Pharmaceutical Science (formerly Ashley Publications). ISSN: 1474-0338.

Expert Opinion on Drug Safety (EODS) is a new bimonthly journal providing comprehensive coverage of the safety of new and established drug therapies. With the ever-expanding armamentarium of drugs and drug therapies available, rational pharmacotherapy today is a complex art. At the forefront of this problem is the need to provide the most effective drug regimen whilst avoiding any adverse drug reactions. From the first point of concept to establishment on the market, monitoring the safety of a drug is critical to a drug's development and commercialisation. With pharmaceutical pipelines burgeoning and further growth of medicines likely in the post-genomic era, there is rapid expansion in the quantity of primary data relating to drug safety. Through systematic review and evaluation, Expert Opinion on Drug Safety seeks to unravel this vast amount of information and provide clear and informed guides to this increasingly important area.